Kadambavanasund Papavinasasundaram
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 32 | 2026 | 420 | 3.070 |
Why?
|
| Tuberculosis | 15 | 2026 | 308 | 1.520 |
Why?
|
| Bacterial Proteins | 16 | 2026 | 741 | 1.190 |
Why?
|
| Antitubercular Agents | 7 | 2025 | 82 | 1.030 |
Why?
|
| Mycobacterium smegmatis | 7 | 2021 | 73 | 0.820 |
Why?
|
| Cell Wall | 4 | 2022 | 118 | 0.520 |
Why?
|
| Gene Deletion | 5 | 2019 | 312 | 0.500 |
Why?
|
| Type VII Secretion Systems | 2 | 2025 | 8 | 0.420 |
Why?
|
| Macrophages | 10 | 2025 | 1037 | 0.380 |
Why?
|
| Peptidoglycan | 4 | 2021 | 55 | 0.300 |
Why?
|
| Chromosomes, Bacterial | 2 | 2018 | 43 | 0.280 |
Why?
|
| Tuberculosis, Pulmonary | 4 | 2005 | 122 | 0.270 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2026 | 146 | 0.250 |
Why?
|
| Pyruvate, Orthophosphate Dikinase | 1 | 2026 | 1 | 0.250 |
Why?
|
| Citrates | 1 | 2026 | 19 | 0.240 |
Why?
|
| Mice | 17 | 2026 | 11114 | 0.240 |
Why?
|
| Iron | 2 | 2024 | 155 | 0.230 |
Why?
|
| Operon | 3 | 2017 | 31 | 0.220 |
Why?
|
| Genetic Fitness | 1 | 2025 | 35 | 0.220 |
Why?
|
| Glucans | 1 | 2025 | 66 | 0.210 |
Why?
|
| Mycobacteriaceae | 1 | 2024 | 2 | 0.210 |
Why?
|
| Antigens, Bacterial | 2 | 2023 | 201 | 0.200 |
Why?
|
| Bacillus | 1 | 2023 | 14 | 0.200 |
Why?
|
| Virulence | 7 | 2026 | 199 | 0.190 |
Why?
|
| Lipids | 1 | 2025 | 328 | 0.180 |
Why?
|
| Carbon | 1 | 2022 | 52 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 279 | 0.180 |
Why?
|
| Drug Interactions | 1 | 2022 | 124 | 0.180 |
Why?
|
| Animals | 17 | 2026 | 21333 | 0.170 |
Why?
|
| Gene-Environment Interaction | 1 | 2022 | 53 | 0.170 |
Why?
|
| Electron Transport Complex IV | 1 | 2021 | 16 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 333 | 0.170 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2021 | 42 | 0.170 |
Why?
|
| Immune Evasion | 1 | 2021 | 71 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2017 | 38 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 675 | 0.160 |
Why?
|
| Phosphorylation | 6 | 2026 | 962 | 0.160 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 135 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2022 | 394 | 0.150 |
Why?
|
| Phagocytosis | 2 | 2018 | 257 | 0.150 |
Why?
|
| Cholesterol | 2 | 2017 | 261 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2025 | 96 | 0.150 |
Why?
|
| Protein Splicing | 1 | 1998 | 3 | 0.150 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 57 | 0.140 |
Why?
|
| Genetics, Microbial | 1 | 2018 | 11 | 0.140 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 67 | 0.140 |
Why?
|
| Rec A Recombinases | 1 | 1998 | 36 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2019 | 96 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 206 | 0.140 |
Why?
|
| Vaccines, Attenuated | 1 | 2018 | 35 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 730 | 0.140 |
Why?
|
| Asymmetric Cell Division | 1 | 2017 | 5 | 0.130 |
Why?
|
| NADPH Oxidase 2 | 1 | 2017 | 36 | 0.130 |
Why?
|
| Tuberculosis Vaccines | 1 | 2018 | 31 | 0.130 |
Why?
|
| Mycobacterium bovis | 1 | 2017 | 29 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 72 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 639 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 116 | 0.130 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 4 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 241 | 0.120 |
Why?
|
| Genotype | 3 | 2022 | 673 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 3481 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2017 | 398 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 256 | 0.110 |
Why?
|
| DNA, Recombinant | 1 | 2015 | 47 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2016 | 283 | 0.110 |
Why?
|
| Mycobacterium | 1 | 2015 | 37 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 801 | 0.110 |
Why?
|
| Gene Editing | 1 | 2018 | 328 | 0.110 |
Why?
|
| Siderophores | 2 | 2024 | 12 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 2015 | 113 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2293 | 0.090 |
Why?
|
| Recombination, Genetic | 4 | 2018 | 255 | 0.090 |
Why?
|
| Regulon | 1 | 2010 | 6 | 0.080 |
Why?
|
| Porins | 2 | 2002 | 63 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2012 | 3149 | 0.080 |
Why?
|
| Mycolic Acids | 2 | 2020 | 16 | 0.080 |
Why?
|
| Phenotype | 2 | 2022 | 1232 | 0.080 |
Why?
|
| Ligands | 2 | 2023 | 415 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2005 | 869 | 0.070 |
Why?
|
| Lung | 3 | 2025 | 964 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2008 | 59 | 0.070 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 117 | 0.060 |
Why?
|
| Humans | 11 | 2024 | 65141 | 0.060 |
Why?
|
| Ethambutol | 1 | 2005 | 4 | 0.060 |
Why?
|
| Nitrites | 1 | 2005 | 12 | 0.060 |
Why?
|
| Pyrazinamide | 1 | 2025 | 7 | 0.060 |
Why?
|
| Clofazimine | 1 | 2025 | 5 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 27 | 0.060 |
Why?
|
| INDEL Mutation | 1 | 2025 | 20 | 0.060 |
Why?
|
| Disulfides | 1 | 2024 | 67 | 0.050 |
Why?
|
| Heme | 1 | 2023 | 30 | 0.050 |
Why?
|
| Phagosomes | 2 | 2017 | 44 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2019 | 341 | 0.050 |
Why?
|
| Nitrate Reductases | 1 | 2003 | 3 | 0.050 |
Why?
|
| Plasmids | 2 | 2018 | 294 | 0.050 |
Why?
|
| Drug Carriers | 1 | 2025 | 188 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2004 | 351 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 742 | 0.050 |
Why?
|
| Peroxidases | 1 | 2001 | 6 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2011 | 1554 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1566 | 0.040 |
Why?
|
| DNA Damage | 1 | 2003 | 298 | 0.040 |
Why?
|
| Mutation | 3 | 2018 | 2661 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 129 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 131 | 0.040 |
Why?
|
| Threonine | 2 | 2012 | 15 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2020 | 184 | 0.040 |
Why?
|
| Antioxidants | 1 | 2001 | 249 | 0.040 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 9 | 0.040 |
Why?
|
| DNA Gyrase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2001 | 321 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2019 | 47 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 56 | 0.040 |
Why?
|
| Folic Acid | 1 | 2019 | 42 | 0.040 |
Why?
|
| Pandemics | 1 | 2024 | 675 | 0.040 |
Why?
|
| Female | 5 | 2025 | 34030 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1998 | 49 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 128 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 1998 | 115 | 0.030 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2018 | 20 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2021 | 791 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 21 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 1998 | 147 | 0.030 |
Why?
|
| Cell Size | 1 | 2017 | 41 | 0.030 |
Why?
|
| BCG Vaccine | 1 | 2018 | 57 | 0.030 |
Why?
|
| Immunization | 1 | 2018 | 135 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 61 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2017 | 77 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 115 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1162 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 518 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 292 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 237 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 464 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2018 | 238 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 153 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 247 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 574 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 419 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 237 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2015 | 28 | 0.030 |
Why?
|
| Electroporation | 1 | 2015 | 36 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 268 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1698 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 453 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2188 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2017 | 2156 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2018 | 918 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 11 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 31 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 48 | 0.020 |
Why?
|
| Cathepsins | 1 | 2011 | 34 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 111 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 139 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 223 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 148 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 61 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1979 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 137 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2010 | 153 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 277 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 542 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 343 | 0.020 |
Why?
|
| Male | 2 | 2022 | 31055 | 0.020 |
Why?
|
| Lysosomes | 1 | 2008 | 173 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 90 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 133 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 384 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 391 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 1639 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 1100 | 0.010 |
Why?
|
| AraC Transcription Factor | 1 | 2004 | 1 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 710 | 0.010 |
Why?
|
| Computational Biology | 1 | 2007 | 367 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 1329 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 1225 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2004 | 176 | 0.010 |
Why?
|
| Nitrosation | 1 | 2003 | 2 | 0.010 |
Why?
|
| Alkylation | 1 | 2003 | 12 | 0.010 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2003 | 11 | 0.010 |
Why?
|
| Nitrates | 1 | 2003 | 21 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 2002 | 38 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2007 | 714 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2001 | 2 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2001 | 83 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 261 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 794 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 364 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 300 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1589 | 0.010 |
Why?
|